Company Overview of MultiGene Vascular Systems (MGVS) Ltd.
MultiGene Vascular Systems (MGVS) Ltd. develops therapeutic products for heart and blood vessel disorders. Its products include MultiGeneAngio, a cell therapy product for alleviating symptoms and signs of ischemia in patients with peripheral arterial disease and coronary artery disease; and MultiGeneGraft, a biosynthetic vascular graft lined with the patient's own endothelial cells that provides improved biocompatibility for patients undergoing bypass surgery for peripheral arterial disease, as well as for renal disease patients who need hemodialysis access site. The company was founded in 2000 and is based in Haifa, Israel.
Lady Davis Carmel Medical Center
7 Michal Street
Founded in 2000
972 4 824 5444
972 4 825 0936
Key Executives for MultiGene Vascular Systems (MGVS) Ltd.
Similar Private Companies By Industry
|SynVaccine Ltd||Middle East/Africa|
|Natural Compounds||Middle East/Africa|
|Brainstorm Cell Therapeutics Ltd||Middle East/Africa|
|OPKO Biologics||Middle East/Africa|
|Advanced Neuroprotective System Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact MultiGene Vascular Systems (MGVS) Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.